PARNASSUS INVESTMENTS, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 948669
San Francisco, CA
Position in ALNY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$16,209,652
-$1,509,632 QoQ
Shares Held
48,991
+9.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARNASSUS INVESTMENTS, LLC holds $91,193,382 across 3 Biotechnology names.
All Filings in ALNY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,209,652 | 48,991 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $17,719,284 | 44,560 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,878,384 | 37,014 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $12,199,679 | 37,412 | Shares | Sole | 2025-08-06 | |
| 2024-03-31 | $5,790,888 | 38,748 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,416,754 | 38,748 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,862,270 | 38,748 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $5,198,155 | 25,970 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,464,842 | 58,038 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $12,669,181 | 77,587 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $13,157,203 | 77,587 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $14,649,201 | 77,587 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $13,152,548 | 77,587 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $10,954,508 | 77,587 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $10,083,982 | 77,587 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||